SEC 13F Intelligence

Exome Asset Management LLC / TARS

Exome Asset Management LLC’s Tarsus Pharmaceuticals Inc Position

Does Exome Asset Management LLC own Tarsus Pharmaceuticals Inc (TARS)? Not currently — the last reported position was 28.2K shares worth $2M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2024
Shares
28.2K
% of Portfolio
+1.17%
Quarters Held
4
position exited

Position History TARS

Reported value by quarter
Q4 ’23: $2MQ4 ’23Q1 ’24: $2MQ1 ’24Q3 ’24: $1MQ3 ’24Q4 ’24: $2MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202428.2K$2M+1.17%
Q3 202445.6K$1M+1.03%
Q1 202466.3K$2M+2.06%
Q4 202384.4K$2M+1.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of TARS.